#nuvalent News & Analysis

2 articles tagged with #nuvalent. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.

2 articles

GeneralBullishBlockonomi · 5h ago6/10

📰

Nuvalent (NUVL) Stock Soars 39% as GSK Announces $10.6B Acquisition

GlaxoSmithKline announced a $10.6 billion acquisition of Nuvalent at $124 per share, causing the biotech company's stock to surge 39%. This represents GSK's largest acquisition in over a decade and signals significant strategic investment in oncology therapeutics.

GeneralNeutralBlockonomi · 13h ago5/10

📰

GSK (GSK) Stock Slides 3% Following $10.6B Nuvalent Acquisition Deal

GSK announced a $10.6 billion acquisition of Nuvalent, a move that triggered a 3% decline in GSK stock. The deal brings two late-stage lung cancer therapeutics into GSK's pipeline, with FDA approval anticipated in 2026, representing the company's continued investment in oncology despite immediate market skepticism.